MANUEL COBO DOLS – ENSAYO CLÍNICO CON MEDICAMENTOS – SUMMIT THERAPEUTICS, INC.
A Randomized, Double-blind, Multi-center, Phase III Study of AK112 or Placebo Combined with Pemetrexed and Carboplatin in Patients with EGFR-mutant Locally Advanced or Metastatic Non-squamous NSCLC Who Have Failed to EGFR-TKI Treatment (HARMONi)
por prodriguez | Jul 3, 2024 | Ensayos Clínicos, Ensayos Clínicos - CIMO-02 | 0 Comentarios